Wharton's Jelly stem cell therapy
Regenerative Medicine · Source Science

Wharton's Jelly — the gold standard in stem cell therapy

Not all stem cells are equal. Wharton's Jelly — the gelatinous tissue inside the umbilical cord — contains the youngest, most potent mesenchymal stem cells available. Here's why it matters, and why we use nothing else.

The Source

What is Wharton's Jelly, exactly?

Wharton's Jelly is the gelatinous connective tissue that surrounds the blood vessels inside the umbilical cord. It was first described by English physician Thomas Wharton in 1656 — but its significance in regenerative medicine wasn't understood until the early 2000s, when researchers discovered it contains an exceptionally high density of mesenchymal stem cells (MSCs).

These MSCs are the same type of cell found in bone marrow and adipose tissue — but with a critical difference: they come from neonatal tissue. That means they're younger, divide faster, secrete more growth factors, and carry a lower immune rejection risk than cells harvested from adult donors.

The umbilical cord is discarded after birth. By collecting it from consenting mothers after healthy, full-term deliveries, we access one of the most potent regenerative sources in the human body — without any harm to mother or child.

Wharton's Jelly mesenchymal stem cells
10–100×
More MSCs per gram
vs bone marrow
Why It Matters

Why Wharton's Jelly outperforms every other MSC source

The regenerative medicine field has tested bone marrow, adipose tissue, dental pulp, and placenta. Wharton's Jelly consistently produces the highest-quality MSCs across every meaningful metric.

Highest MSC concentration

Wharton's Jelly contains 10–100× more MSCs per gram than bone marrow aspirate. More cells means more signaling, more anti-inflammatory activity, and more regenerative potential per treatment.

Younger, more potent cells

Neonatal MSCs divide faster, secrete more growth factors, and have longer telomeres than adult-derived cells. Age matters in regenerative medicine — and Wharton's Jelly starts at day zero.

Immune-privileged — no rejection drugs

Wharton's Jelly MSCs express low MHC class II antigens. The immune system tolerates them without immunosuppressants — a significant safety advantage over other allogeneic therapies.

Ethically sourced, rigorously tested

All tissue is donated by consenting mothers after healthy, full-term births. Every lot is tested for sterility, viability, potency, and freedom from communicable disease before release.

In-home stem cell therapy delivery
Delivery

Delivered in your home by a licensed clinician

We don't run a clinic. We come to you. A licensed nurse practitioner — operating under Dr. Sean Arora and Arora Health Group — delivers your Wharton's Jelly treatment in your home, office, or hotel room.

The treatment itself is a targeted injection to the affected joint or tissue. Most sessions take 30–60 minutes. There's no general anesthesia, no surgical prep, and no recovery room. You can return to light activity the same day.

  • No clinic visit — we come to you
  • Licensed NP under physician oversight
  • Targeted injection to affected area
  • 30–60 minute session
  • Available in all 50 states
See if you qualify
FAQ

Wharton's Jelly questions answered

What is Wharton's Jelly and why is it used in stem cell therapy?

Wharton's Jelly is the gelatinous connective tissue inside the umbilical cord. It contains one of the highest concentrations of mesenchymal stem cells (MSCs) found in the human body. Because these cells come from newborn tissue, they are younger, more proliferative, and carry a lower immune rejection risk than adult-derived stem cells.

How is Wharton's Jelly different from bone marrow or fat-derived stem cells?

Bone marrow and adipose (fat) stem cells are autologous — taken from your own body. They decline in quality and quantity with age. Wharton's Jelly MSCs are allogeneic (donor-sourced) from ethically donated umbilical cords, meaning they are younger, more potent, and available in consistent, high-quality supply without a painful harvest procedure.

Is Wharton's Jelly therapy safe?

Yes. Wharton's Jelly MSCs are immune-privileged — they express low levels of MHC class II antigens, which means the body rarely mounts a rejection response. All products we use are sourced from AATB-accredited tissue banks and tested for sterility, viability, and potency before use.

What conditions can Wharton's Jelly stem cell therapy address?

Our protocols focus on musculoskeletal conditions: osteoarthritis, joint degeneration, soft-tissue injuries, tendon and ligament damage, and chronic inflammation. We do not treat systemic diseases or conditions outside our clinical scope.

How is Wharton's Jelly therapy administered?

Treatment is delivered via targeted injection to the affected area by a licensed nurse practitioner in your home. No surgery, no clinic visit, no general anesthesia. Most sessions take 30–60 minutes.

Get Started

Not sure where to start?
Take the 2-minute quiz.

We'll route you to the right clinician and the right program. If you're not a fit for any of them, we'll tell you that too. That's the whole point.

Take The 2-Minute Quiz

Regenerative therapies are provided as a concierge medical service following an in-person consultation. We do not sell stem cell or exosome products online.